Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 28521 [2014-11357]

Download as PDF Federal Register / Vol. 79, No. 95 / Friday, May 16, 2014 / Notices other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Gary J. Johnson, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Prevention and the Agency for Toxic Substances and Disease Registry. Gary J. Johnson, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–11355 Filed 5–15–14; 8:45 am] BILLING CODE 4163–18–P [FR Doc. 2014–11365 Filed 5–15–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Advisory Council for the Elimination of Tuberculosis Meeting (ACET) EMCDONALD on DSK67QTVN1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following council meeting. Times and Dates: 8:30 a.m.–5:00 p.m., June 9, 2014; 8:30 a.m.–2:30 p.m., June 10, 2014. Place: CDC, Corporate Square, Building 8, 1st Floor Conference Room, Atlanta, Georgia 30333, telephone (404) 639–8317. This meeting is also accessible by teleconference. Toll-free +1 (877) 927–1433, Participant code: 12016435. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 100 people. Purpose: This council advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis. Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis. Matters for Discussion: Agenda items include the following topics: (1) U.S. Preventive Services Task Force/Assessing Evidence for treatment of Latent Tuberculosis Infection (LTBI) as prevention; (2) TB screening activities in Federally Qualified Health Centers (FQHCs); (3) Advanced Molecular Detection (AMD); (4) Updates from Workgroups; and (5) other tuberculosisrelated issues. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Margie Scott-Cseh, Centers for Disease Control and Prevention, 1600 Clifton Road NE., M/S E–07, Atlanta, Georgia 30333, telephone (404) 639–8317; Email: zkr7@ cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and VerDate Mar<15>2010 20:00 May 15, 2014 Jkt 232001 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Pilot Interventions to Promote the Health of People with Blood Disorders, FOA DD14–003, initial review. SUMMARY: This document corrects a notice that was published in the Federal Register on March 19, 2014 (79 FR 15349–15350). The times and dates should read as follows: Time and Date: 9:00 a.m.–3:30 p.m., April 8, 2014 (Closed) FOR FURTHER INFORMATION CONTACT: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F46, Atlanta, Georgia 30341, Telephone: (770) 488–3585, EEO6@ cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Gary J. Johnson, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. 28521 Awareness about Dementia, including Alzheimer’s Disease, Special Interest Projects (SIP)14–003; Promoting Public Health Understanding of Dementia, SIP14–004; and Evaluating Cost Information about Alzheimer’s Disease and Dementia, SIP14–005, Panel G, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 9:30 a.m.–4:00 p.m., June 6, 2014 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Public Health Communications: Culturally Relevant Messages and Strategies to Promote Awareness about Dementia, Including Alzheimer’s Disease, SIP14–003; Promoting Public Health Understanding of Dementia, SIP14–004; and Evaluating Cost Information about Alzheimer’s Disease and Dementia, SIP14–005, Panel G,’’ initial review. Contact Person for More Information: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F–80, Atlanta, Georgia 30341, Telephone: (770) 488–3585, EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Gary J. Johnson, Acting Director, Management Analysis and Services Office Centers for Disease Control and Prevention. [FR Doc. 2014–11366 Filed 5–15–14; 8:45 am] BILLING CODE 4163–18–P [FR Doc. 2014–11357 Filed 5–15–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Public Health Communications: Culturally Relevant Messages and Strategies to Promote PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 The meeting announced below concerns Progestin Contraception and HIV Risk: Clinical and Laboratory Follow-up of a Cohort of HIV-Infected and Uninfected Women, Special Interest Project (SIP)14–023, Panel E, initial review. E:\FR\FM\16MYN1.SGM 16MYN1

Agencies

[Federal Register Volume 79, Number 95 (Friday, May 16, 2014)]
[Notices]
[Page 28521]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-11357]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Pilot Interventions to Promote 
the Health of People with Blood Disorders, FOA DD14-003, initial 
review.

SUMMARY: This document corrects a notice that was published in the 
Federal Register on March 19, 2014 (79 FR 15349-15350). The times and 
dates should read as follows:
    Time and Date: 9:00 a.m.-3:30 p.m., April 8, 2014 (Closed)

FOR FURTHER INFORMATION CONTACT: M. Chris Langub, Ph.D., Scientific 
Review Officer, CDC, 4770 Buford Highway NE., Mailstop F46, Atlanta, 
Georgia 30341, Telephone: (770) 488-3585, EEO6@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Gary J. Johnson,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2014-11357 Filed 5-15-14; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.